Cargando…
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns()
Individuals with substance use disorders (SUDs), including those in long-term recovery, and their loved ones are facing rapid changes to treatment and support services due to COVID-19. To assess these changes, the Addiction Policy Forum fielded a survey to their associated patient and family network...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577266/ https://www.ncbi.nlm.nih.gov/pubmed/33127196 http://dx.doi.org/10.1016/j.jsat.2020.108180 |
_version_ | 1783598165671280640 |
---|---|
author | Mellis, Alexandra M. Potenza, Marc N. Hulsey, Jessica N. |
author_facet | Mellis, Alexandra M. Potenza, Marc N. Hulsey, Jessica N. |
author_sort | Mellis, Alexandra M. |
collection | PubMed |
description | Individuals with substance use disorders (SUDs), including those in long-term recovery, and their loved ones are facing rapid changes to treatment and support services due to COVID-19. To assess these changes, the Addiction Policy Forum fielded a survey to their associated patient and family networks between April 27 and May 13, 2020. Individuals who reported a history of use of multiple substances were more likely to report that COVID-19 has affected their treatment and service access, and were specifically more likely to report both use of telehealth services and difficulties accessing needed services. These findings suggest that individuals with a history of using multiple substances may be at greater risk for poor outcomes due to COVID-19, even in the face of expansion of telehealth service access. |
format | Online Article Text |
id | pubmed-7577266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75772662020-10-22 COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() Mellis, Alexandra M. Potenza, Marc N. Hulsey, Jessica N. J Subst Abuse Treat Article Individuals with substance use disorders (SUDs), including those in long-term recovery, and their loved ones are facing rapid changes to treatment and support services due to COVID-19. To assess these changes, the Addiction Policy Forum fielded a survey to their associated patient and family networks between April 27 and May 13, 2020. Individuals who reported a history of use of multiple substances were more likely to report that COVID-19 has affected their treatment and service access, and were specifically more likely to report both use of telehealth services and difficulties accessing needed services. These findings suggest that individuals with a history of using multiple substances may be at greater risk for poor outcomes due to COVID-19, even in the face of expansion of telehealth service access. Elsevier Inc. 2021-02 2020-10-21 /pmc/articles/PMC7577266/ /pubmed/33127196 http://dx.doi.org/10.1016/j.jsat.2020.108180 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mellis, Alexandra M. Potenza, Marc N. Hulsey, Jessica N. COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title | COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title_full | COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title_fullStr | COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title_full_unstemmed | COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title_short | COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
title_sort | covid-19-related treatment service disruptions among people with single- and polysubstance use concerns() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577266/ https://www.ncbi.nlm.nih.gov/pubmed/33127196 http://dx.doi.org/10.1016/j.jsat.2020.108180 |
work_keys_str_mv | AT mellisalexandram covid19relatedtreatmentservicedisruptionsamongpeoplewithsingleandpolysubstanceuseconcerns AT potenzamarcn covid19relatedtreatmentservicedisruptionsamongpeoplewithsingleandpolysubstanceuseconcerns AT hulseyjessican covid19relatedtreatmentservicedisruptionsamongpeoplewithsingleandpolysubstanceuseconcerns |